Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Chr. Hansen Holding A/S    CHR   DK0060227585

CHR. HANSEN HOLDING A/S

(CHR)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe Europe - 01/28 04:49:28 am
546.2 DKK   -0.73%
01/26CHR HANSEN A/S : Manager's transactions
AQ
01/25CHR HANSEN A/S : Sustainability roadshow presentation (January 2021)
PU
01/18CHR HANSEN A/S : Q1 Conference call transcript 2020/21
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Chr Hansen A/S : Resolutions passed at the Annual General Meeting of Chr. Hansen Holding A/S

11/25/2020 | 12:27pm EST

Company announcement no. 29/2020

At the Annual General Meeting of Chr. Hansen Holding A/S held on Wednesday November 25, 2020 the following proposals set out in the agenda were adopted: 

  • The Annual Report 2019/20.
  • Not to pay out an ordinary dividend for 2019/20. Instead an extraordinary dividend is expected to be paid out at least equal to a normalized dividend for 2019/20 after the divestment of Natural Colors.
  • The advisory vote on the 2019/20 Remuneration Report.
  • To maintain the same remuneration level in 2020/21 for the members of the Board of Directors and the board committee members as in 2019/20, to change the denomination of travel allowance for 2020/21 from EUR to DKK and to increase the travel allowance for travelling between continents from previously EUR 3,000 to DKK 37,500.
  • Amendments to the Company’s Articles of Association:
    • Amendment of the standard agenda of the Annual General Meeting
    • Authorisation to the Board of Directors to resolve to hold partial or full electronic general meetings
    • Allow shareholder attendance based on notification rather than ordering admission cards.
  • Re-election of Dominique Reiniche as Chair of the Board of Directors.
  • Re-election of Jesper Brandgaard, Luis Cantarell, Heidi Kleinbach-Sauter and Mark Wilson as members of the Board of Directors.
  • Election of Lise Kaae, Kevin Lane and Lillie Li Valeur as new members of the Board of Directors.
  • Re-election of PricewaterhouseCoopers, Statsautoriseret Revisionspartnerselskab as auditor of the Company.
  • The proposal that the Board of Directors must complete an assessment of the ability of the Company to publish country-by-country tax reporting in line with the Global Reporting Initiative’s Standard (GRI 207: Tax 2019) starting from the financial year 2021/22, the findings of which should be made public before the AGM in 2021.
  • Authorization of the Chairman of the Annual General Meeting to file the resolutions passed with the Danish Business Authority and to make any such changes as the Danish Business Authority may require as a condition for registering or approving the resolutions passed.

The following proposal was not adopted: 

  • The proposal that going forward and starting from the 2020/21 financial year, the Company must apply the recommendations of the Task Force on Climate-related Financial Disclosures (TCFD) as the framework for climate-related disclosure in the Company’s Annual Report.

For further information please contact:

Martin Riise, Senior Director, Investor Relations, Tel: +45 5339 2250
Annika Stern, Investor Relations Officer, Tel: +45 2399 2382
Camilla Lercke, Head of Media Relations, Tel: +45 5339 2384

 

About Chr. Hansen

Chr. Hansen is a global, differentiated bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. At Chr. Hansen we are uniquely positioned to drive positive change through microbial solutions. We have worked for over 145 years to enable sustainable agriculture, cleaner labels and healthier living for more people around the world. Our microbial and fermentation technology platforms, including our broad and relevant collection of around 40,000 microbial strains, have game-changing potential. Matching customer needs and global trends we continue to unlock the power of good bacteria to respond to global challenges such as food waste, global health and the overuse of antibiotics and pesticides. As the world’s most sustainable food ingredients company, we touch the lives of more than 1 billion people every day. Driven by our legacy of innovation and curiosity to pioneer science, our purpose –  To grow a better world. Naturally. – is at the heart of everything we do.

Attachment

  • No 29 Resolutions passed at Annual General Meeting of Chr. Hansen Holding AS

© OMX, source OMX

All news about CHR. HANSEN HOLDING A/S
01/26CHR HANSEN A/S : Manager's transactions
AQ
01/25CHR HANSEN A/S : Sustainability roadshow presentation (January 2021)
PU
01/18CHR HANSEN A/S : Q1 Conference call transcript 2020/21
PU
01/15CHR HANSEN A/S : Manager's transactions
AQ
01/14CHR HANSEN A/S : . Hansen Fiscal Q1 Profit Falls While Revenue Jumps
MT
01/14CHR HANSEN A/S : Q1 Roadshow presentation 2020/21
PU
01/14CHR HANSEN A/S : Q1 Interim report 2020/21
PU
01/14CHR HANSEN A/S : Q1 Factsheet 2020/21
PU
01/14CHR HANSEN A/S : Q1 Conference call presentation 2020/21
PU
01/14CHR HANSEN A/S : . Hansen reports strong organic growth of 10% for Q1
PU
More news
Financials
Sales 2021 1 081 M 1 306 M 1 306 M
Net income 2021 869 M 1 050 M 1 050 M
Net Debt 2021 887 M 1 072 M 1 072 M
P/E ratio 2021 11,1x
Yield 2021 1,25%
Capitalization 9 737 M 11 793 M 11 770 M
EV / Sales 2021 9,83x
EV / Sales 2022 9,10x
Nbr of Employees 3 286
Free-Float 77,9%
Chart CHR. HANSEN HOLDING A/S
Duration : Period :
Chr. Hansen Holding A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CHR. HANSEN HOLDING A/S
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 12
Average target price 76,75 €
Last Close Price 73,91 €
Spread / Highest target 25,5%
Spread / Average Target 3,84%
Spread / Lowest Target -14,5%
EPS Revisions
Managers and Directors
NameTitle
Mauricio Graber President & Chief Executive Officer
Dominique Reiniche Chairman
Lise Skaarup Mortensen Chief Financial Officer & Executive Vice President
Thomas Schäfer Chief Scientific Officer & Executive VP
Mark Anthony Wilson Independent Director